Other Clinical Trial - China Greenlight Registry Study (Post-market)

Status Completed

Clinical Trial Summary

The duration of the study is expected to take approximately 3 years, which includes a recruitment period of approximately 12-months and 2 years (24-months) to complete procedure and follow-up visits.

Clinical Trial Description

The study follow-up duration from the primary study procedure is 5 years. - Baseline - Study Procedure - 4-week - 6-month - 12-month - 24-month (End of Study) The study will be considered complete after all subjects have completed the 24-month follow-up visit. ;

Study Design

Related Conditions & MeSH terms

Benign Prostatic Hyperplasia (BPH)
Hyperplasia
Prostatic Hyperplasia

Clinical Trial Details

NCT number	NCT03736512
Study type	Observational [Patient Registry]
Source	Boston Scientific Corporation
Contact
Status	Completed
Phase
Start date	February 27, 2019
Completion date	November 29, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03052049` - Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres	N/A
Recruiting	`NCT04757116` - Post-Market Study to Assess iTind Safety in Comparison to UroLift	N/A
Completed	`NCT03460873` - Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate
Completed	`NCT01218243` - An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia	Phase 2
Completed	`NCT01566292` - Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy	Phase 2/Phase 3
Active, not recruiting	`NCT00407953` - PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)	Phase 4
Completed	`NCT03191734` - French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue	N/A
Recruiting	`NCT04838769` - REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men	N/A
Completed	`NCT03856242` - Benign Prostatic Hyperplasia and Ischemic Heart DIsease	Phase 4
Completed	`NCT04032067` - Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)	Phase 3
Completed	`NCT02505919` - Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)	N/A
Completed	`NCT02855892` - A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH	Phase 2
Completed	`NCT02145208` - Study to Assess the Efficacy of Medi-Tate iTind Device	N/A
Completed	`NCT00970632` - A Study of Tadalafil in Men With Benign Prostatic Hyperplasia	Phase 3
Recruiting	`NCT02592473` - Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia	N/A
Completed	`NCT00945490` - Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018	Phase 3
Completed	`NCT00759135` - Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)	Phase 2
Completed	`NCT00224107` - A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo	Phase 3
Recruiting	`NCT04648176` - Application of MOSES Technology in BPH	N/A
Terminated	`NCT00651807` - A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)	Phase 2